- Home
- VNRX vs TLPH Comparison
VNRX vs TLPH Comparison
Compare VNRX & TLPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VNRX
- TLPH
- Stock Information
- Founded
- VNRX N/A
- TLPH 2005
- Country
- VNRX United States
- TLPH United States
- Employees
- VNRX N/A
- TLPH N/A
- Industry
- VNRX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- TLPH Biotechnology: Pharmaceutical Preparations
- Sector
- VNRX Health Care
- TLPH Health Care
- Exchange
- VNRX Nasdaq
- TLPH Nasdaq
- Market Cap
- VNRX 69.7M
- TLPH 64.7M
- IPO Year
- VNRX N/A
- TLPH 2011
- Fundamental
- Price
- VNRX $0.41
- TLPH $1.19
- Analyst Decision
- VNRX Strong Buy
- TLPH Strong Buy
- Analyst Count
- VNRX 4
- TLPH 1
- Target Price
- VNRX $3.50
- TLPH $6.00
- AVG Volume (30 Days)
- VNRX 1.2M
- TLPH 314.5K
- Earning Date
- VNRX 11-14-2025
- TLPH 11-12-2025
- Dividend Yield
- VNRX N/A
- TLPH N/A
- EPS Growth
- VNRX N/A
- TLPH N/A
- EPS
- VNRX N/A
- TLPH N/A
- Revenue
- VNRX $1,319,252.00
- TLPH $27,000.00
- Revenue This Year
- VNRX $324.32
- TLPH N/A
- Revenue Next Year
- VNRX $247.82
- TLPH $14,533.26
- P/E Ratio
- VNRX N/A
- TLPH N/A
- Revenue Growth
- VNRX 35.10
- TLPH N/A
- 52 Week Low
- VNRX $0.40
- TLPH $0.38
- 52 Week High
- VNRX $0.94
- TLPH $1.45
- Technical
- Relative Strength Index (RSI)
- VNRX 32.66
- TLPH 51.72
- Support Level
- VNRX $0.42
- TLPH $1.12
- Resistance Level
- VNRX $0.48
- TLPH $1.42
- Average True Range (ATR)
- VNRX 0.04
- TLPH 0.09
- MACD
- VNRX 0.00
- TLPH -0.01
- Stochastic Oscillator
- VNRX 4.14
- TLPH 35.14
About VNRX VolitionRX Limited
VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.
About TLPH Talphera Inc.
Talphera Inc. is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. The Company's nafamostat product candidates include Niyad and LTX-608. Its portfolio consists of nafamostat product candidates and pre-filled syringe product candidates.